Hopstem Closes First Series C Financing to Advance iPSC Neural Cell Therapy

Hopstem Biotechnology Inc., a Houston-based biotechnology company developing induced pluripotent stem cell-derived neural cell therapies, announced the first closing of... Read More

The post Hopstem Closes First Series C Financing to Advance iPSC Neural Cell Therapy appeared first on citybiz.